This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ciervo, A. Articles by Cassone, A. Search for Related Content PubMed PubMed Citation Articles by Ciervo, A. Articles by Cassone, A.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, January 2002, p. 66-74, Vol. 9, No. 1
1071-412X/01/$04.00+0     DOI: 10.1128/CDLI.9.1.66-74.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Antibodies to 60-Kilodalton Heat Shock Protein and Outer Membrane Protein 2 of Chlamydia pneumoniae in Patients with Coronary Heart Disease

Alessandra Ciervo,¹ Paolo Visca,^2,3 Andrea Petrucca,³ Luigi Maria Biasucci,⁴ Attilio Maseri,⁴ and Antonio Cassone^1*

Department of Bacteriology and Medical Mycology, Istituto Superiore di Sanità,¹ Department of Biology, Università di Roma Tre,² Molecular Microbiology Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani,",³ Institute of Cardiology, Università Cattolica del Sacro Cuore, Rome, Italy⁴

Received 8 June 2001/ Returned for modification 10 August 2001/ Accepted 21 September 2001

Evidence linking Chlamydia pneumoniae infection to atherosclerosis and to atherothrombotic events has recently emerged. A primary candidate implicated in these pathogenetic events is the 60-kDa chlamydial heat shock protein (HSP60). Another putative candidate to activate a potential proinflammatory mechanism is the chlamydial outer membrane protein 2 (OMP2). We have generated both HSP60 and OMP2 recombinant antigens in a nondenatured form and shown that (i) the two antigens were highly immunogenic in mice and (ii) murine antisera thus generated recognized the native C. pneumoniae proteins. We measured by enzyme linked immunosorbent assay (ELISA) and immunoblot assay antibody titers to the recombinant antigens in samples from 219 patients with coronary heart disease (CHD), 179 patients with unstable angina (UA), 40 patients with acute myocardial infarction (AMI), and 100 age-, sex-, and risk factor-matched healthy controls. We also examined whether anti-HSP60 and/or anti-OMP2 antibodies correlated with anti-C. pneumoniae antibodies assessed by a commercial microimmunofluorescence (MIF) assay. Immunoglobulin G (IgG), but neither IgA nor IgM, antibodies against the two recombinant proteins were detected by ELISA. In particular, anti-HSP60 antibodies were detected in >99% of CHD patients versus 0% of the controls, whereas the proportions of anti-OMP2 positive subjects were >70 and 27%, respectively. Nonetheless, among CHD patients, similar frequencies of positive subjects and titers of anti-HSP60 or anti-OMP2 antibodies were present in UA and AMI subjects. The anti-OMP2, but not the anti-HSP60, antibodies showed high specificity. Consistently, high serological correlation was observed between IgG MIF titers and IgG ELISA reactivity to OMP2 but not to HSP60. Overall, the results of this study demonstrate a strong correlation between CHD and anti-HSP60 IgG levels, as measured by our in-house ELISA. They also suggest that recombinant OMP2 ELISA, because of its high specificity and strong correlation with MIF assay, could be a candidate diagnostic marker for C. pneumoniae infection, which would be of potential usefulness for its specificity and nonsubjective nature.

---

* Corresponding author. Mailing address: Istituto Superiore di Sanità, Department of Bacteriology and Medical Mycology, Viale Regina Elena 299, 00161 Rome, Italy. Phone: (39) 6-49387113. Fax: (39) 6-49902934. E-mail: cassone{at}iss.it.

---

Clinical and Diagnostic Laboratory Immunology, January 2002, p. 66-74, Vol. 9, No. 1
1071-412X/01/$04.00+0     DOI: 10.1128/CDLI.9.1.66-74.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Benagiano, M., D'Elios, M. M., Amedei, A., Azzurri, A., van der Zee, R., Ciervo, A., Rombola, G., Romagnani, S., Cassone, A., Del Prete, G. (2005). Human 60-kDa Heat Shock Protein Is a Target Autoantigen of T Cells Derived from Atherosclerotic Plaques. J. Immunol. 174: 6509-6517 [Abstract] [Full Text]  
• Vojdani, A., Bazargan, M., Vojdani, E., Samadi, J., Nourian, A. A., Eghbalieh, N., Cooper, E. L. (2004). Heat Shock Protein and Gliadin Peptide Promote Development of Peptidase Antibodies in Children with Autism and Patients with Autoimmune Disease. CVI 11: 515-524 [Abstract] [Full Text]  
• Biasucci, L. M., Liuzzo, G., Ciervo, A., Petrucca, A., Piro, M., Angiolillo, D. J., Crea, F., Cassone, A., Maseri, A. (2003). Antibody Response to Chlamydial Heat Shock Protein 60 Is Strongly Associated With Acute Coronary Syndromes. Circulation 107: 3015-3017 [Abstract] [Full Text]  
• Benagiano, M., Azzurri, A., Ciervo, A., Amedei, A., Tamburini, C., Ferrari, M., Telford, J. L., Baldari, C. T., Romagnani, S., Cassone, A., D'Elios, M. M., Del Prete, G. (2003). T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 100: 6658-6663 [Abstract] [Full Text]  
• Klein, M., Kotz, A., Bernardo, K., Kronke, M. (2003). Detection of Chlamydia pneumoniae-Specific Antibodies Binding to the VD2 and VD3 Regions of the Major Outer Membrane Protein. J. Clin. Microbiol. 41: 1957-1962 [Abstract] [Full Text]  
• Xu, Q. (2002). Role of Heat Shock Proteins in Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 22: 1547-1559 [Abstract] [Full Text]  
• Mahdi, O. S., Horne, B. D., Mullen, K., Muhlestein, J. B., Byrne, G. I. (2002). Serum Immunoglobulin G Antibodies to Chlamydial Heat Shock Protein 60 but Not to Human and Bacterial Homologs Are Associated With Coronary Artery Disease. Circulation 106: 1659-1663 [Abstract] [Full Text]